Peptide Synthesis Market Size

Peptide Synthesis Market size was over USD 690.75 million in 2024 and is poised to reach USD 1.56 billion by the end of 2037, growing at around 7.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of peptide synthesis is assessed at USD 729.98 million.

The market growth can be attributed to the escalating integration of precision medicines and the high demand for personalized medicine. The development of personalized medicines enables doctors to tailor treatments to each individual patient’s oriented needs and characteristics. Thus, with increasing investment in the R&D of precise medicines the demand for peptide synthesis is expected to increase in the future.

Besides, there are more factors behind the expansion of the peptide synthesis market such as rising emphasis on protein-based therapeutics such as recombinant proteins, and the high prevalence of cardiovascular diseases, reported by the World Health Organization every year around 17.9 million deaths take place globally due to cardiovascular diseases.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of peptide synthesis is assessed at USD 729.98 million.

The peptide synthesis market size was over USD 690.75 million in 2024 and is poised to reach USD 1.56 billion by the end of 2037, growing at around 7.1% CAGR during the forecast period i.e., between 2025-2037. Growing expenditure by the pharmaceutical industry on R&D along with growth in drug approvals and high usage in COVID-19 treatment will propel the market growth.

North America industry is slated to dominate reveue share by 2037, backed by government and academic institutions increasing efforts to create innovative peptide-based medicinal pharmaceuticals in the region.

The major players in the market include CordenPharma International, Evonik, CSBio Company Inc., Bachem Holding, AGBiotage, AAPP Tec, CEM Corporation, ProteoGenix, GenScript, Thermo Fisher Scientific Inc.

Peptide Synthesis Market Size